Shyamala Navada, MD | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Shyamala Navada, MD

  1. Home
Position / Title: 
Associate Professor of Medicine, Hematology and Medical Oncology
Institution: 
Mount Sinai Medical Center
Online Profile: 
https://www.mountsinai.org/profiles/shyamala-navada
Primary Disease Area of Focus: 
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)

Dr. Navada is an assistant professor in the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City.  She attended medical school at the University of Illinois at Chicago.  Subsequently, she did an Internal Medicine Residency at the University of Michigan in Ann Arbor prior to completing a hematology/oncology fellowship at Mount Sinai.  She is currently completing a Masters of Science in Clinical Research in the graduate school at Mount Sinai.  Her primary clinical and research interests are myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) in the elderly.  She will be the principal investigator of a clinical trial combining azacitidine and rigosertib in MDS patients that will soon be opening at Mount Sinai.

Practice Location: 
Mount Sinai Medical Center
New York City , NY 10029 ,
US
Physician Status: 
  • accepting new patients

Other pages on our site that mention Shyamala Navada:

  1. Research Article - Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study
  2. Research Article - Myelodysplastic Syndromes: A Review of Therapeutic Progress Over the Past 10 Years